HarrisMartin's Syngenta GMO Corn Litigation Conference Speaker Profiles

A co-founder of Simmons Hanly Conroy, Ms. Conroy is an experienced litigator who enjoys a superb national reputation as a skilled strategist, trial lawyer and negotiator. For many years Ms. Conroy acted as national trial and coordinating defense counsel to a multi-national corporation and several of its subsidiaries. In recent years she has represented plaintiffs exclusively in a wide variety of products liability matters. Currently her practice focuses on plaintiffs’ pharmaceutical actions on behalf of several thousand plaintiffs who were administered the drugs Actos, OxyContin, Zelnorm, Zyprexa, Vioxx, Celebrex, Bextra, gadolinium contrast dyes, Ephedra, Chantix, Yazmin and Yaz, as well as plaintiffs who were injured by medical devices such as DePuy artificial hips and pelvic repair system materials.

Ms. Conroy serves or has served as a member of Plaintiffs’ Steering or Executive Committees in nearly a dozen multidistrict pharmaceutical litigations, and is credited with orchestrating the settlements between 2006 and the present of thousands of pharmaceutical cases for a total recovery for the firm’s clients that approaches $300 million. Throughout much of 2008 Ms. Conroy was engaged in negotiating the terms of the landmark, $894 million settlement of Bextra and Celebrex cases against Pfizer. Ms. Conroy has also represented several thousand victims of the September 11, 2001 tragedy in a multi-district action against the financial sponsors of terrorism, and, in a separate set of negligence litigations against the airlines and airport security companies on behalf of 50 families who lost their loved ones on the four 9/11 aircraft, helped to forge settlements that totaled in the hundreds of millions of dollars.

Roger has spent his entire career representing seriously injured individuals, including railroad employees and victims of dangerous products and defective pharmaceutical drugs. He has litigated cases in more than a dozen states, both in state and federal courts.

Roger has a national reputation as a leader in pharmaceutical litigation. Roger is acting as MDL Liaison Counsel in Yasmin/Yaz litigation, having been appointed by Chief Judge David Herndon, of the Southern District of Illinois. Roger is also lead counsel in the NuvaRing MDL, having been appointed by Judge Rodney Sippel of the Eastern District of Missouri. Roger has served on the National Plaintiffs' Steering Committees in the Ortho Evera MDL Litigation, appointed by Judge David A. Katz, of the Northern District of Ohio, as well as the Gadolinium MDL, appointed by Judge Dan A. Polster, of the Northern District of Ohio.

Roger is also active in the HRT Litigation in the City of St. Louis, Missouri Circuit Court, where he is representing women throughout the country who have Breast Cancer caused by hormone replacement drugs. There are more than 10,000 women nationally who have developed breast cancer because of these dangerous drugs.

Scott Love concentrates his practice in the areas of products liability, personal injury, wrongful death, mass tort litigation and class action litigation. Over the course of his career, Scott has distinguished himself as one of the leading mass tort and trial lawyers in the country. Currently, Scott is one of only a handful of lawyers in the United States to obtain multiple multi-million dollar verdicts in pharmaceutical and medical device cases.
In addition to his active trial practice, Scott has been selected to leadership roles in numerous consumer class actions and mass tort cases, including, insurance cases, oil & gas cases and various pharmaceutical cases such as Trasylol, Paxil, Accutane, Topamax, Zoloft, and Transvaginal Mesh.
Scott was recently appointed as national counsel on the Plaintiffs' Steering Committee for the Transvaginal Mesh federal Multi-District litigation pending in West Virginia by the Honorable Judge Goodwin. Scott currently serves on the Plaintiffs' Steering Committee for the following MDLs:

In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation, MDL No. 2325

In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2187

In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2327

In Re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation, MDL No. 2326

Scott was also one of the leading attorneys in the national Trasylol litigation which was transferred to the Southern District of Florida. Scott was honored with the appointment of co-lead counsel of the Plaintiff's Steering Committee by the Honorable Donald Middlebrooks in May 2008. As co-lead counsel of the PSC, Scott was responsible for coordinating the overall litigation strategy which has successfully resulted in the settlement of all of the cases pending across the country.